A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories

Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
A 15-Year Jump in Life Expectancy for People With HIV
Life Expectancy for Young People With HIV Is Nearly Normal
Failure to Awaken Dormant Cells Deals Blow to HIV Cure Research
Scientists Devise Method of Snipping HIV From Immune Cells
Media Cooks Up Claim That Soy Sauce Treats, Even Cures HIV
FDA Approves New Single-Tablet HIV Regimen, Triumeq
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to news@aidsmeds.com.

Click here for more news


emailprint

October 19, 2011

Death Rates Among People With HIV Vary Considerably From State to State, CDC Reports

Death rates among people with HIV are more than twice as great in many Southern states compared with other states, even after adjusting for racial and age differences, according to a sobering new analysis reported by U.S. Centers for Disease Control and Prevention (CDC) researchers. The findings, published online ahead of print by the journal AIDS, also suggest that death rates among people with HIV are high even in states where people with HIV make up a small percentage of age-matched deaths documented in the general population.

HIV remains a major public health concern in the United States. About 53,000 new infections continue to occur annually, and while deaths due to HIV infection declined dramatically after the introduction of potent antiretroviral (ARV) therapy in the mid-1990s, the decline in death rates has slowed in recent years.

The National HIV/AIDS Strategy for the United States has prioritized the reduction of health disparities among demographic groups, notably women and people of color. However, such disparities may be largely dependent on geography, given that health care access varies with state policies regarding funding for medical care, prescription drugs and supportive services. Yet few studies have examined interstate disparities in HIV-related health outcomes in the modern-day treatment era. Such data are needed to refine funding streams in ways to help meet National HIV/AIDS Strategy goals.

To explore the important issue of geographic survival disparities, David Hanna, MS, and his CDC colleagues evaluated two sets of data in 37 states, representing 70 percent of the U.S. population, fully participating in the national HIV/AIDS Reporting System. They first looked at the rates of deaths of people living with HIV—deaths from any cause, not necessarily HIV-related health problems—compared with those of the general HIV-negative population. Then they looked at death rates exclusively among people living with HIV. In both analyses, interstate comparisons were made.

After adjusting for age, the researchers found that death rates among people with HIV, as a percentage of the general population, were highest in New York, New Jersey, North Carolina, South Carolina, Florida, Louisiana and Mississippi and lowest in northern Midwest states. These results are not surprising, as the states with the highest HIV-associated deaths are among the states with the highest HIV prevalence.

Of particular interest was the shift in rankings when the CDC team looked at death rates exclusively among people with HIV in the 37 states included in the analysis. For example, Wyoming’s rank moved up 27 places—whereas it had the second lowest number of deaths (36/37) of people with HIV in the general population, reflecting the low prevalence of HIV in that state, it had the ninth highest death rate (9/37), compared with other states, of people living with HIV dying. 

Similarly, Iowa had the 34th lowest death rate of people with HIV, as a proportion of the state’s general population, but it had the 17th highest death rate when only counting people with HIV, compared with other states.

Rankings of death rates among people living with HIV also increased in Oklahoma, Arkansas, Alabama and Tennessee.

In states like New York and Connecticut, ranked 3rd and 12th in terms of HIV-associated death rates as percentages of the general population, death rates as percentages of people with HIV were among the lowest: They ranked 30th and 35th out of 37 states, respectively.

Other states demonstrated no major change in ranks. For example, Louisiana had the second highest rates of deaths of HIV-positive people, both in its general population and among its residents living with HIV, compared with other states. In Mississippi, Florida and the Carolinas death rates among people living with HIV were doubled those documented in many Northeastern, Midwestern and Pacific states.

The comparatively low death rates among people living with HIV in states such as New York and Connecticut, the CDC team writes, “suggests good secondary and tertiary prevention of HIV disease, which could be due in part to earlier screening or entry into care, better adherence to medical instructions, or better care, compared to many other states.”

In states where death rates are highest among residents with HIV, they add, the study findings “[suggest] that services to those with HIV may be inadequate.”

“The elimination of HIV-related health disparities is a national priority,” Hanna and his CDC colleagues conclude. “Our study shows that state of residence should be considered as a geographic unit of analysis when assessing disparities, in addition to categorizations like sex, race/ethnicity, and transmission category. Our findings also support earlier work identifying disparities in the [Southern United States] for earlier consequences of HIV infection, namely AIDS diagnosis. Examination of these rate disparities is a crucial step in addressing their causes, and can guide policymakers to consider area-level factors as well as individual factors when choosing interventions.”

Search: CDC, death, mortality, states, Mississippi, Louisiana, Florida, North Carolina, South Carolina, New York, Connecticut, Hanna, disparities


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team reviews all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (5 total)


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dversescott
    Baltimore
    Maryland


    Sin_Grinder
    Reno
    Nevada


    Fred9774
    Brooklyn
    New York


    humboman
    Baltimore
    Maryland
Click here to join POZ Personals!
Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.